# CVS Settles Federal Prescription Claims

CVS agreed to pay **$315 million** to resolve federal allegations of unlawful controlled-substance dispensing and false claims to federal healthcare programs. Under a separate agreement with the Drug Enforcement Administration (DEA), CVS must establish a public and employee reporting hotline, proactively monitor dispensing patterns, and review potentially problematic prescribers. The resolution is an enforcement development, not a procurement award, but it is relevant to pharmacies and other organizations participating in federal healthcare programs because it highlights scrutiny of compliance controls and claims practices.

- CVS’s DEA agreement specifies safeguards including reporting channels, dispensing-pattern monitoring, and prescriber review; these are concrete reference points for evaluating pharmacy compliance programs.
- The settlement highlights potential federal exposure related to both controlled-substance dispensing and claims submitted to healthcare programs. Organizations should assess whether their own controls address those risks, without treating CVS’s agreement as a new general mandate.
- Federal healthcare buyers and contractors may find the case relevant to evaluating contractor integrity, operational controls, and risk in pharmacy-related services.

**Jurisdictions:** federal
**Industries:** Healthcare
**Topics:** Regulatory Compliance
**Published:** October 13, 2026

### Government Entities
- U.S. Department of Justice (DOJ)
- Drug Enforcement Administration (DEA)
- U.S. Department of Health and Human Services Office of Inspector General (HHS-OIG)

### Vendors
- CVS (settling party)

### Key Quotes
> Pharmacies that dispense controlled substances must maintain effective compliance systems to identify and respond to warning signs that prescriptions may be unlawful or medically unnecessary.
> — Charles C. Calenda, First Assistant U.S. Attorney for the District of Rhode Island

> This settlement agreement highlights DEA’s commitment to protecting the health and safety of Americans while holding CVS accountable for dispensing unlawful prescriptions and endangering the public.
> — Cheri Oz, DEA Assistant Administrator

### Sources
- [ Office of Public Affairs |  CVS Agrees to Pay $315M for Illegally Filling Unlawful Opioid Prescriptions and for Submitting False Claims to the Federal Government | United States Department of Justice](https://www.justice.gov/opa/pr/cvs-agrees-pay-315m-illegally-filling-unlawful-opioid-prescriptions-and-submitting-false) - DOJ
- [CVS Agrees to Pay $315M for Illegally Filling Unlawful Opioid Prescriptions and for Submitting False Claims to the Federal Government](https://www.dea.gov/press-releases/2026/10/13/cvs-agrees-pay-315m-for-illegally-filling-unlawful-opioid-prescriptions) - DEA